Day 8 monocyte and lymphocyte counts as a novel and early predictor for discontinuation in gynecologic cancer patients receiving paclitaxel and carboplatin therapy: a retrospective observational study
Abstract Background Maintaining optimal treatment intensity is essential for therapeutic efficacy in gynecological malignancies undergoing paclitaxel plus carboplatin (TC) chemotherapy; however, myelosuppression frequently results in treatment delay or interruption, which can compromise long-term ou...
Збережено в:
| Автори: | , , , |
|---|---|
| Формат: | Artigo |
| Мова: | Inglês |
| Опубліковано: |
BMC
2026-02-01
|
| Серія: | Journal of Pharmaceutical Health Care and Sciences |
| Предмети: | |
| Онлайн доступ: | https://doi.org/10.1186/s40780-026-00547-5 |
| Теги: |
Немає тегів, Будьте першим, хто поставить тег для цього запису!
|